相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunisation route-dependent expression of IL-4/IL-13 can modulate HIV-specific CD8+ CTL avidity
Charani Ranasinghe et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Improving vaccines by targeting antigens to dendritic cells
Ken Shortman et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Enhanced Induction of Intestinal Cellular Immunity by Oral Priming with Enteric Adenovirus 41 Vectors
Sung-Youl Ko et al.
JOURNAL OF VIROLOGY (2009)
Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults
Mark Wallace et al.
MOLECULAR THERAPY (2009)
Vaccination with combination of Fit3L and RANTES in a DNA prime-protein boost regimen elicits strong cell-mediated immunity and antitumor effect
Shuxia Song et al.
VACCINE (2009)
Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes
Rogerio S. Rosada et al.
BMC IMMUNOLOGY (2008)
Is intranasal vaccination a feasible solution for tuberculosis?
Pramod K. Giri et al.
EXPERT REVIEW OF VACCINES (2008)
The failed HIV Merck vaccine study: A step back or a launching point for future vaccine development?
Rafick-Pierre Sekaly
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIVmac251 Mucosal Challenge
Thorsten Demberg et al.
JOURNAL OF VIROLOGY (2008)
DNA vaccines: ready for prime time?
Michele A. Kutzler et al.
NATURE REVIEWS GENETICS (2008)
Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
Max Corbett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals
Jun Liu et al.
VACCINE (2008)
Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
A. Guimaraes-Walker et al.
VACCINE (2008)
EV02:: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
Sheena McCormack et al.
VACCINE (2008)
Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization
Igor M. Belyakov et al.
VIROLOGY (2008)
Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses
Xianggang Huang et al.
VACCINE (2007)
Influence of IFNγ co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy
S. Emery et al.
HUMAN VACCINES (2007)
Differential functional avidity of dengue virus-specific T-Cell clones for variant peptides representing heterologous and previously encountered serotypes
Allison Imrie et al.
JOURNAL OF VIROLOGY (2007)
Should a new tuberculosis vaccine be administered intranasally?
Gunilla Kallenius et al.
TUBERCULOSIS (2007)
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B
Carmen Elena Gomez et al.
VACCINE (2007)
Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques
Robert De Rose et al.
JOURNAL OF VIROLOGY (2007)
4-1BBL coexpression enhances HIV-specific CD8 T cell memory in a poxvirus prime-boost vaccine
Jodie M. Harrison et al.
VACCINE (2006)
Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1
Charani Ranasinghe et al.
VACCINE (2006)
Gut-associated lymphoid tissue-primed CD4+ T cells display CCR9-dependent and -independent homing to the small intesfine
H Stenstad et al.
BLOOD (2006)
Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa
E Cox et al.
VETERINARY RESEARCH (2006)
Impact of vaccine-induced mucosal high-avidity CD8+CTLs in delay of AIDS viral dissemination from mucosa
IM Belyakov et al.
BLOOD (2006)
MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis
Eva Perez-Jimenez et al.
MICROBES AND INFECTION (2006)
Antigen-specific T cell responses: Determination of their frequencies, homing properties, and effector functions in human whole blood
T Breinig et al.
METHODS (2006)
A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1
AD Kelleher et al.
AIDS (2006)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
Recombinant poxviruses as mucosal vaccine vectors
MM Gherardi et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3
SJ Kent et al.
VACCINE (2005)
SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques
JD Boyer et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2005)
Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity
FN Toka et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy
J Stambas et al.
VACCINE (2005)
High-avidity CD8(+) T cells - Optimal soldiers in the war against viruses and tumors
MA Alexander-Miller
IMMUNOLOGIC RESEARCH (2005)
Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A
JE Epstein et al.
VACCINE (2004)
Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein
PF Wright et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Profiling the CD8low phenotype, an alternative career choice for CD8 T cells during primary differentiation
N Kienzle et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Modulation of CD8+ T cell avidity by increasing the turnover of viral antigen during infection
PM Gray et al.
CELLULAR IMMUNOLOGY (2004)
Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNγ or IL-12
CJ Dale et al.
VACCINE (2004)
Gut-homing (α4β7+) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors
C Krieg et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Mucosal HIV vaccines: Where are we now?
L Stevceva et al.
CURRENT HIV RESEARCH (2004)
Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag
HT Zhang et al.
JOURNAL OF VIROLOGY (2004)
Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein
RB Wang et al.
JOURNAL OF IMMUNOLOGY (2004)
Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines
DH Barouch et al.
JOURNAL OF VIROLOGY (2003)
Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes
MM Gherardi et al.
JOURNAL OF VIROLOGY (2003)
Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration
JC Ramirez et al.
ARCHIVES OF VIROLOGY (2003)
The role of mucosal immunity in prevention of HIV transmission
PA Kozlowski et al.
CURRENT MOLECULAR MEDICINE (2003)
A DNA prime-live vaccine boost strategy in mice can augment IFN-γ responses to mycobacterial antigens but does not increase the protective efficacy of two attenuated strains of Mycobacterium bovis against bovine tuberculosis
MA Skinner et al.
IMMUNOLOGY (2003)
DNA injection in combination with electroporation: A novel method for vaccination of farmed ruminants
S Tollefsen et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2003)
The combination of DNA vectors expressing IL-12+IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK
E Tapia et al.
MICROBES AND INFECTION (2003)
Mucosal priming of simian immunodeficiency virus-specific cytotoxic T-lymphocyte responses in rhesus macaques by the Salmonella type III secretion antigen delivery system
DT Evans et al.
JOURNAL OF VIROLOGY (2003)
Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination
J Baig et al.
JOURNAL OF VIROLOGY (2002)
A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L
JD Ahlers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Protection by SIVVLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration
E O'Neill et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2002)
Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239
H Horton et al.
JOURNAL OF VIROLOGY (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population
MJ Estcourt et al.
INTERNATIONAL IMMUNOLOGY (2002)
Emergence and kinetics of simian immunodeficiency virus-specific CD8+ T cells in the intestines of macaques during primary infection
RS Veazey et al.
JOURNAL OF VIROLOGY (2001)
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?
SL Rowland-Jones et al.
IMMUNOLOGY LETTERS (2001)
Prime-boost immunization with DNA vaccine: Mucosal route of administration changes the rules
SK Eo et al.
JOURNAL OF IMMUNOLOGY (2001)
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
RR Amara et al.
SCIENCE (2001)
Enhancement of mucosal immune response against HIV-1 Gag by DNA immunization
I Yoshizawa et al.
VACCINE (2001)
Vaccination strategies for mucosal immune responses
PL Ogra et al.
CLINICAL MICROBIOLOGY REVIEWS (2001)
Expression of mucosal homing receptor α4β7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo
RA Hawkins et al.
INFECTION AND IMMUNITY (2000)
Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids
JD Boyer et al.
AIDS (2000)
Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 Env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent:: Suppressive effects of IL-12 boost are mediated by nitric oxide
MM Gherardi et al.
JOURNAL OF VIROLOGY (2000)
Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection
MA Alexander-Miller
CELLULAR IMMUNOLOGY (2000)
Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines
JJ Kim et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
TM Allen et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
